CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 226 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03538262
NCT03538262N/ACompleted
CompareCT.gov

Tele-health Outcomes as Digital Biomarkers of Parkinson's Disease Progression During Extended Follow up of STEADY-PD3 and SURE-PD3 Trial Participants

Massachusetts General Hospital·observational·Posted May 29, 2018·Updated Jun 12, 2023

In Brief

An observational study for Parkinson Disease. Completed, enrolled 226 participants across 1 site.

Detailed Summary

An observational study to characterize and compare long-term clinical outcomes data collected remotely through periodic tele-visits, interactive smartphone app sessions, and web-based surveys in individuals with Parkinson's Disease (PD) who have completed the interventional phases of the STEADY-PD3 and SURE-PD3 clinical trials.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesUnited States
CollaboratorsNorthwestern University, Sage Bionetworks, University of Rochester, National Institute of Neurological Disorders and Stroke (NINDS), Michael J. Fox Foundation for Parkinson's Research, The Parkinson Study Group

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 29, 2018
Enrollment StartOct 1, 2018
Primary CompletionMar 21, 2022
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 8.1 years ago